Long-Term Effect of Combination of Creatine Monohydrate Plus β-Hydroxy β-Methylbutyrate (HMB) on Exercise-Induced Muscle Damage and Anabolic/Catabolic Hormones in Elite Male Endurance Athletes
Fernández-Landa J, Fernández-Lázaro D, Calleja-González J, Caballero-García A, Córdova A, León-Guereño P, Mielgo-Ayuso J
Biomolecules · 15 citations
How it was studied
- Design
- Randomized controlled trial (classified by our AI screen)
- Studied in
- People
- Main outcome
- Health markers and function
Who paid for it
- Funding
- Independent funding
Based on full-text disclosure statement.
Publication
- Published
- 2020-01-15 · Biomolecules · vol. 10 · issue 1 · p. 140
- Publisher
- Multidisciplinary Digital Publishing Institute
- Cited
- 24 citations · more than 77% of similar papers · 1.4× the field average
- References
- 72 works
- Access
- Open access (journal) · CC-BY
- Research areas
- Muscle metabolism and nutrition · Exercise and Physiological Responses · Sports Performance and Training
- Keywords
- Anabolism, Endocrinology, Internal medicine, Testosterone (patch), Creatine, Placebo, Hormone, Creatine kinase, Creatine Monohydrate, Catabolism, Medicine, Metabolism
- MeSH
- muscle, skeletal, humans, creatine, valerates, testosterone, hydrocortisone, exercise, double-blind method, placebo effect, dietary supplements, adult, male, athletes
7 authors
From ES
- Julen Fernández-LandaUniversity of the Basque Country
- Diego Fernández‐LázaroUniversidad de Valladolid
- Julio Calleja-GonzálezUniversity of the Basque Country
- Alberto Caballero-GarcíaUniversidad de Valladolid
- Alfredo C CordovaUniversidad de Valladolid
- Patxi León-GuereñoUniversidad de Deusto
Abstract
Creatine monohydrate (CrM) and β-hydroxy β-methylbutyrate (HMB) are widely studied ergogenic aids. However, both supplements are usually studied in an isolated manner. The few studies that have investigated the effect of combining both supplements on exercise-induced muscle damage (EIMD) and hormone status have reported controversial results. Therefore, the main purpose of this study was to determine the effect and degree of potentiation of 10 weeks of CrM plus HMB supplementation on EIMD and anabolic/catabolic hormones. This study was a double-blind, placebo-controlled trial where participants (n = 28) were randomized into four different groups: placebo group (PLG; n = 7), CrM group (CrMG; 0.04 g/kg/day of CrM; n = 7), HMB group (HMBG; 3 g/day of HMB; n = 7), and CrM-HMB group (CrM-HMBG; 0.04 g/kg/day of CrM plus 3 g/day of HMB; n = 7). Before (baseline, T1) and after 10 weeks of supplementation (T2), blood samples were collected from all rowers. There were no significant differences in the EIMD markers (aspartate aminotransferase, lactate dehydrogenase, and creatine kinase) among groups. However, we observed significant differences in CrM-HMBG with respect to PLG, CrMG, and HMBG on testosterone (p = 0.006; η2p = 0.454) and the testosterone/cortisol ratio (T/C; p = 0.032; η2p = 0.349). Moreover, we found a synergistic effect of combined supplementation on testosterone (CrM-HMBG = -63.85% vs. CrMG + HMBG = -37.89%) and T/C (CrM-HMBG = 680% vs. CrMG + HMBG = 57.68%) and an antagonistic effect on cortisol (CrM-HMBG = 131.55% vs. CrMG + HMBG = 389.99%). In summary, the combination of CrM plus HMB showed an increase in testosterone and T/C compared with the other groups after 10 weeks of supplementation. Moreover, this combination presented a synergistic effect on testosterone and T/C and an antagonistic effect on cortisol compared with the sum of individual or isolated supplementation.
Abstract via Europe PMC. Copyright remains with the authors or publisher (CC BY).
Community trust
Loading…
How much do you trust this study's findings?
Comments
Sign in to rate, comment on or flag this study.Sign inSomething wrong here?
Flag this study if its information, labels or funding look wrong. An editor reviews every flag.
Sign in to rate, comment on or flag this study.Sign inEducational information about published research. Not medical advice, and not a recommendation to start or stop anything.